__CONFIG_colors_palette__{"active_palette":0,"config":{"colors":{"eb08a":{"name":"Main Accent","parent":-1},"19fff":{"name":"Accent Transparent","parent":"eb08a","lock":{"lightness":1}}},"gradients":[]},"palettes":[{"name":"Default","value":{"colors":{"eb08a":{"val":"var(--tcb-skin-color-0)","hsl":{"h":36,"s":0.4225,"l":0.6333,"a":1}},"19fff":{"val":"rgba(190, 152, 96, 0.05)","hsl_parent_dependency":{"h":36,"l":0.56,"s":0.42}}},"gradients":[]},"original":{"colors":{"eb08a":{"val":"rgb(55, 179, 233)","hsl":{"h":198,"s":0.8,"l":0.56,"a":1}},"19fff":{"val":"rgba(55, 179, 233, 0.05)","hsl_parent_dependency":{"h":198,"s":0.8,"l":0.56,"a":0.05}}},"gradients":[]}}]}__CONFIG_colors_palette__
  • Nav #1
  • Nav #2
  • Nav #3
    • Subnav#1
    • Subnav#2
  • Nav #4
  • Nav#5
  • Login
  • Log out

Search here:

  • Home
  • Archives: Press Releases
On May 31, 2023

AAHI Presents Advancements In Vaccine Formulations and Methodology at Modern Vaccines Adjuvant Delivery Systems Conference 2023

On March 6, 2023

The Access to Advanced Health Institute Reports Encouraging Results of First-In-Human Trial of Its Temperature-Stable Tuberculosis Vaccine Candidate

On February 15, 2023

The Access to Advanced Health Institute Announces $3M Award to Develop an Intranasal Pan-Viral Countermeasure against Respiratory Viruses

On February 6, 2023

The Access to Advanced Health Institute Announces $9.9M Award to Develop a Nasal Spray Influenza RNA Vaccine Through Phase 1 Clinical Trials

On November 2, 2022

AAHI Develops Longer Lasting and Broadly Protective SARS-CoV-2 RNA Vaccine Candidate that is Stable at Room Temperature

On November 1, 2022

AAHI to Present Novel Applications of Its Unique Self-Amplifying RNA Vaccine Platform at the 10th International mRNA Health Conference

 Load More

Discover My Latest Book: [Book Name]

More here

New

book Title
  • Books
  • Events

©2023, Casey Benadof. All rights reserved.

  • Privacy Policy
  • Disclaimer